Association between COVID‐19 and sensorineural hearing loss: Evidence from a Mendelian randomization study in European and East Asian population
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.1108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Fengyang Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Henan Provincial Institute of Medical Genetics, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: COVID-19, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reserve Talents of Young and Middle-aged Academic and Technical Leaders in Yunnan Province.
Abstract (Originalsprache)
Background
Long coronavirus disease (COVID), characterized by persistent and sometimes debilitating symptoms following a severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has garnered increasing attention as a potential public health crisis. Emerging evidence indicates a higher incidence of hearing loss in individuals who have had COVID 2019 (COVID‐19) compared to the general population. However, the conclusions were inconsistent, and the causal relationship between COVID‐19 and sensorineural hearing loss remains unknown.
Methods
To addresses this outstanding issue, we performed Mendelian randomization analysis to detect the causal association between COVID‐19 and hearing loss using the largest genome‐wide association study data to date in the European population and confirmed the results in the East Asian population. Comprehensively sensitive analyses were followed, including Cochran's Q test, Mendelian randomization (MR)‐Egger intercept test, MR‐pleiotropy residual sum and outlier, and leave‐one‐out analysis, to validate the robustness of our results.
Results
Our results suggested that there is no causal association between COVID‐19 and the risk of hearing loss in the European population. Neither the susceptibility, hospitalization, and severity of COVID‐19 on hearing loss (inverse variance weighted method: odds ratio (OR) = 1.046, 95% confidence interval (CI) = 0.907–1.205, p = .537; OR = 0.995, 95% CI = 0.956–1.036, p = .823; OR = 0.995, 95% CI = 0.967–1.025, p = .76). Replicated analyses in the East Asian population yielded consistent results. No pleiotropy and heterogeneity were found in our results.
Conclusion
In conclusion, our MR results do not support a genetically predicted causal relationship between COVID‐19 and sensorineural hearing loss. Thus, the associations observed in prior observational studies may have been influenced by confounding factors rather than a direct cause‐and‐effect relationship. More clinical and mechanism research are needed to further understand this association in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henan Provincial Institute of Medical Genetics, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, China.
- State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences, Yunnan University, Kunming, China.
ORCID-Profile: Lei Zhu
Förderung
- Reserve Talents of Young and Middle-aged Academic and Technical Leaders in Yunnan Province
Zitieren
APA
Wang, F., Yin, Q., & Zhu, L. (2023). Association between COVID‐19 and sensorineural hearing loss: Evidence from a Mendelian randomization study in European and East Asian population. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1108
Vancouver
Wang F, Yin Q, Zhu L. Association between COVID‐19 and sensorineural hearing loss: Evidence from a Mendelian randomization study in European and East Asian population. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.1108
BibTeX
@article{Wang2023,
author = {Wang, Fengyang and Yin, Qiuyuan and Zhu, Lei},
title = {Association between COVID‐19 and sensorineural hearing loss: Evidence from a Mendelian randomization study in European and East Asian population},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.1108}
}
EUVIMED